Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

2002986 citationsJournal Articlebronze Open Access

Authors

Thomas J. Walsh · National Cancer Institute

Peter G. Pappas · University of Alabama at Birmingham

Drew J. Winston · University of California, Los Angeles

Hillard M. Lazarus · University Hospitals of Cleveland

Finn Bo Petersen · University of Utah

John Raffalli · New York Medical College

Saul Yanovich

Abstract

Voriconazole is a suitable alternative to amphotericin B preparations for empirical antifungal therapy in patients with neutropenia and persistent fever.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Neutropenia and Cancer Infections

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 346, Issue 4, pp. 225-234

DOI: 10.1056/nejm200201243460403

Field-Weighted Citation Impact: 42.58